复星国际：上半年归母净利润为6.6亿元 同比下降8.2%

Core Insights - Fosun International (00656.HK) reported a revenue of RMB 87.28 billion for the first half of 2025, representing a year-on-year decline of 10.8% [1] - The top four subsidiaries by revenue—Fosun Pharma, Yuyuan, Fosun Portugal Insurance, and Fosun Tourism—generated a total revenue of RMB 63.61 billion, accounting for 73% of the group's total revenue [1] - The group's operational profit reached RMB 3.15 billion, down 9.3% year-on-year, primarily due to a decline in profits from the leisure business segment [1] - The group's management expenses decreased, and the net profit attributable to shareholders was RMB 660 million, reflecting an 8.2% year-on-year decline [1]